METTL3 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), miR-4443 inhibits the protein expression of methyltransferase-like 3 (METTL3), which is responsible for N6-methyladenosine (m6A) methylation, leading to upregulation of FSP1 expression and regulation of ferroptosis [61].